Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial

2017361 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Neurology

Volume 16, Issue 5, pp. 360-368

Field-Weighted Citation Impact: 23.32